is allulose a glp 1 agonist GLP-1: Genetic Variants Related to GLP-1 RA Medications Allulose is a rare monosaccharide
Description
GLP-1 Receptor Agonist Market Share Companies such as Novo Nordisk, Eli Lilly, AstraZeneca, and Sanofi dominate this market due to their strong research capabilities, innovative drug formulations, and commitment to addressing diabetes and obesity challenges
Glucagon-like peptide-1 receptor agonist liraglutide ameliorates the development of periodontitis
Both obesity and diabetes, which are treated by GLP-1 drugs, are major risk factors for Alzheimers
N.RiviereG
doi: 10.1056/NEJMoa1901118 44 GersteinHCSattarNRosenstockJRamasundarahettigeCPratleyRLopesRDet al
Lajthia E, Bucheit JD, Nadpara PA, Dixon DL, Caldas LM, Murchie M, et al
